The American Society of Plastic Surgeons recommended that gender-affirming surgeries be delayed until a patient is at least ...

At an employee town hall, FDA leaders tried to quell staff concerns about a controversial new program to fast-track certain drugs.

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from ...

Pfizer disclosed that an experimental weight loss drug, recently picked up through its acquisition of Metsera, hit its marks ...

In a pilot, Utah is testing use of AI for renewing drug prescriptions. Experts ask if it should be regulated as a medical ...

Researchers must be mindful of unexpected events that may leave them incapacitated or unable to lead their research projects ...

Pfizer reported weight-loss results for a monthly GLP-1 obesity injection that it acquired as part of the $10 billion Metsera ...

As we reported here last month, new federal guidelines recommend that women ages 30 to 65 can skip pap smears and do an HPV ...

Doctors nationally are describing harrowing consequences for patients who put off medical care because of fears of ICE.

Pfizer reported that its newly acquired weight loss drug showed promise as a monthly treatment, though the field is growing ...

Novo Nordisk on Tuesday said it expects sales and profits to decline this year, as the maker of Wegovy faces growing competition in the obesity market.

The Trump administration is seeking to reduce animal testing in research. Some activists are pushing the administration to suspend primate imports for research purposes entirely.